Research & Discovery
Q&A: Dr. Pramod Srivastava Explains the Hunt for a Breast Cancer Vaccine
The UConn Health team says they're about two years away from starting a clinical trial for triple negative breast cancer vaccines
A Front Row View, an Abundance of Data, and a Glimpse of How Galaxies Evolve
UConn researchers are taking some of the guesswork out of how supermassive black holes merge
UConn Research 2022: Advancing the Mind, Medicine, Society, and Beyond
In 2022, The UConn Research Enterprise achieved breakthroughs across many disciplines and contributed to important conversations on topics that define the times.
Science in Seconds: Cannabinoids
Cannabinoids are able to decrease our capacity to process pain in the brain while having less substance use potential than that of opioids
Third Bridge Grant Program Supports Four UConn Startups
The technologies supported by this year's Third Bridge Grant awards include innovations in patenting, mobility, online education, and Lyme disease prevention.
Joint Symposium Underscores Value of Interdisciplinary Health Research
The event brings together researchers from across UConn's campuses and beyond to explore new approaches to improve human health
UConn Center on Aging to Transform our Understanding of Cellular Senescence in Human Aging with NIH-Funded Tissue Mapping Center Discoveries
The journal Nature Aging has highlighted the new NIH-funded SenNet Consortium that includes an NIH Common Fund U54 Tissue Mapping Center at UConn Health/JAX to better understand senescent cells which underlie aging and chronic disease development.
When it Comes to Disaster Prevention Policies, Who Can We Trust?
If politicians seem shady, voters are less likely to spend on disaster prevention measures
Let’s Get This Party Started: UConn Researcher, Colleagues Discover that Certain Celebrations Can Boost the Health of Participants
The most successful celebrations require a social gathering, with food or drink, and the intentionally marking of a positive life event
UConn Collaborates With USDA To Develop African Swine Fever Vaccine Candidate Licensed by Zoetis
One of the world’s largest animal health companies non-exclusively licensed the USDA and UConn’s jointly owned vaccine candidate for African swine fever, a lethal disease in pigs